• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH INNOVANCE ANTITHROMBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH INNOVANCE ANTITHROMBIN Back to Search Results
Model Number INNOVANCE ANTITHROMBIN
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/14/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted a siemens customer care center (ccc).Quality controls (qc) recovered in range at the time of the event.Siemens is investigating the issue.
 
Event Description
A discordant, falsely low antithrombin (at) result was obtained on a patient sample on a sysmex cs-2500 system using innovance antithrombin reagent.The discordant result was reported to the physician(s) and was questioned.The sample was rerun for at at an alternate laboratory, recovering higher.The higher result was reported, as the correct result, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant at result.
 
Manufacturer Narrative
Siemens filed the initial mdr 9610806-2022-00007 on 18-feb-2022.Additional information (21-feb-2022): the results were evaluted correctly by the sysmex cs-2500 system software.Quality controls (qc) recovered in range and the issue was limited to one patient sample.Compared to the non-siemens assay used at the alternate laboratory, the innovance antithrombin assay uses an incubation time to facilitate an increased sensitivity to heparin binding site mutations.Sample specific interferences cannot be ruled out as a potential cause of the result discrepancy.The cause of the event is unknown.The reagent is performing according to specifications.No further evaluation of this device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVANCE ANTITHROMBIN
Type of Device
INNOVANCE ANTITHROMBIN
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring-str. 76
marburg
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring-str. 76
marburg, D-350 41
GM   D-35041
Manufacturer Contact
christopher aebig
511 benedict ave
tarrytown, NY 10591
9144153450
MDR Report Key13560336
MDR Text Key286226061
Report Number9610806-2022-00007
Device Sequence Number1
Product Code JBQ
UDI-Device Identifier00842768037146
UDI-Public00842768037146
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K081769
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/05/2022
Device Model NumberINNOVANCE ANTITHROMBIN
Device Catalogue Number10709521
Device Lot Number00406
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Age24 YR
Patient SexFemale
-
-